MB076 - CAS 2832966-95-5

MB076 is an innovative heterocyclic triazole designed with enhanced plasma stability. It effectively inhibits seven distinct Class C Acinetobacter-derived cephalosporinases (ADCs) β-lactamase variants with K i values less than 1 μM. Additionally, MB076 demonstrates a synergistic effect when combined with various cephalosporins to restore pBCSK (−) susceptibility [1].

Others, Antibacterial, Antibiotic

Others, Microbiology/Virology

2832966-95-5

C9H12BN7O5S2

373.18

C([C@H](NC(CSC=1SC(N)=NN1)=O)B(O)O)N2C=C(C(O)=O)N=N2

-20°C

Ice Packs

Small Compound